nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.853	1	CbGbCtD
Flecainide—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00609	0.0415	CcSEcCtD
Flecainide—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0259	CcSEcCtD
Flecainide—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00369	0.0251	CcSEcCtD
Flecainide—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00366	0.0249	CcSEcCtD
Flecainide—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0247	CcSEcCtD
Flecainide—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0245	CcSEcCtD
Flecainide—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0236	CcSEcCtD
Flecainide—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00338	0.023	CcSEcCtD
Flecainide—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0218	CcSEcCtD
Flecainide—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0176	CcSEcCtD
Flecainide—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0174	CcSEcCtD
Flecainide—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0025	0.017	CcSEcCtD
Flecainide—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0166	CcSEcCtD
Flecainide—Coma—Riluzole—amyotrophic lateral sclerosis	0.00236	0.0161	CcSEcCtD
Flecainide—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0157	CcSEcCtD
Flecainide—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00222	0.0152	CcSEcCtD
Flecainide—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0147	CcSEcCtD
Flecainide—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0146	CcSEcCtD
Flecainide—Deafness—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0143	CcSEcCtD
Flecainide—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00207	0.0141	CcSEcCtD
Flecainide—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0138	CcSEcCtD
Flecainide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.002	0.0136	CcSEcCtD
Flecainide—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0136	CcSEcCtD
Flecainide—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0128	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0128	CcSEcCtD
Flecainide—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0127	CcSEcCtD
Flecainide—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0122	CcSEcCtD
Flecainide—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0122	CcSEcCtD
Flecainide—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.012	CcSEcCtD
Flecainide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0108	CcSEcCtD
Flecainide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0103	CcSEcCtD
Flecainide—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0102	CcSEcCtD
Flecainide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0101	CcSEcCtD
Flecainide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00992	CcSEcCtD
Flecainide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00967	CcSEcCtD
Flecainide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00962	CcSEcCtD
Flecainide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00941	CcSEcCtD
Flecainide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00921	CcSEcCtD
Flecainide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00902	CcSEcCtD
Flecainide—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00881	CcSEcCtD
Flecainide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00881	CcSEcCtD
Flecainide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00828	CcSEcCtD
Flecainide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.008	CcSEcCtD
Flecainide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00783	CcSEcCtD
Flecainide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0076	CcSEcCtD
Flecainide—Tension—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00756	CcSEcCtD
Flecainide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00755	CcSEcCtD
Flecainide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00749	CcSEcCtD
Flecainide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00722	CcSEcCtD
Flecainide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00715	CcSEcCtD
Flecainide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00695	CcSEcCtD
Flecainide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00693	CcSEcCtD
Flecainide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00691	CcSEcCtD
Flecainide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0069	CcSEcCtD
Flecainide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.001	0.00681	CcSEcCtD
Flecainide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000994	0.00678	CcSEcCtD
Flecainide—Cough—Riluzole—amyotrophic lateral sclerosis	0.000987	0.00673	CcSEcCtD
Flecainide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00098	0.00668	CcSEcCtD
Flecainide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00666	CcSEcCtD
Flecainide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00656	CcSEcCtD
Flecainide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00656	CcSEcCtD
Flecainide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000963	0.00656	CcSEcCtD
Flecainide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00096	0.00654	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000957	0.00652	CcSEcCtD
Flecainide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00648	CcSEcCtD
Flecainide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000942	0.00642	CcSEcCtD
Flecainide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000931	0.00634	CcSEcCtD
Flecainide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000923	0.00629	CcSEcCtD
Flecainide—Shock—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00619	CcSEcCtD
Flecainide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000905	0.00617	CcSEcCtD
Flecainide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00616	CcSEcCtD
Flecainide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000901	0.00614	CcSEcCtD
Flecainide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00611	CcSEcCtD
Flecainide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000893	0.00608	CcSEcCtD
Flecainide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00088	0.006	CcSEcCtD
Flecainide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00588	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00573	CcSEcCtD
Flecainide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000835	0.00569	CcSEcCtD
Flecainide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00565	CcSEcCtD
Flecainide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000823	0.00561	CcSEcCtD
Flecainide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000821	0.00559	CcSEcCtD
Flecainide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000813	0.00554	CcSEcCtD
Flecainide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000803	0.00547	CcSEcCtD
Flecainide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000797	0.00543	CcSEcCtD
Flecainide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00542	CcSEcCtD
Flecainide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00079	0.00538	CcSEcCtD
Flecainide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00079	0.00538	CcSEcCtD
Flecainide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000761	0.00518	CcSEcCtD
Flecainide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000755	0.00514	CcSEcCtD
Flecainide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000734	0.005	CcSEcCtD
Flecainide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00497	CcSEcCtD
Flecainide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00497	CcSEcCtD
Flecainide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000662	0.00451	CcSEcCtD
Flecainide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000653	0.00445	CcSEcCtD
Flecainide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000632	0.0043	CcSEcCtD
Flecainide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00416	CcSEcCtD
Flecainide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000587	0.004	CcSEcCtD
Flecainide—Rash—Riluzole—amyotrophic lateral sclerosis	0.000582	0.00397	CcSEcCtD
Flecainide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000582	0.00396	CcSEcCtD
Flecainide—Headache—Riluzole—amyotrophic lateral sclerosis	0.000578	0.00394	CcSEcCtD
Flecainide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000548	0.00374	CcSEcCtD
